05 Mar Publication of data showing Zorevunersen effects on Dravet Syndrome patients
Stoke Therapeutics, a biotechnology company that works on a proposed...
News
29 Nov Dravet Syndrome Means more than Seizures, New Research Warns
Dravet Syndrome, a rare epilepsy disorder, hides deeper challenges, and...
21 Nov The Dravet Preclinical Research Meeting, a step forward for future therapeutic approaches
The first pan-European meeting on Preclinical Research in Dravet Syndrome,...
09 Nov Dravet Preclinical Research Meeting – 19 November 2025
We are excited to announce the upcoming Dravet Preclinical Research...
01 Jul A Snapshot of Life with Dravet Syndrome
Before the Dravet Syndrome Awareness month, the Dravet Syndrome European...
23 Jun Bloom Forward
On the occasion of Dravet Awareness Day, which we celebrate...
29 Mar Find Clinical Trials near you with new Interactive Map
The European Medicines Agency (EMA) has recently launched a new...
24 Mar 2025 is a great year for Dravet drug research. Learn what’s ahead!
We live in a very interesting period for Dravet Syndrome,...
09 Jan Phase 3 of Zorevunersen Study
Stoke Therapeutics, a biotechnology company that works on a proposed...
25 Sep SCN1A-UP! at the end – Gene therapy approaches
In this video, Dr Gaia Colasante summarizes the strategies and...